Bruker (MIL:1BRKR) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1BRKR Bruker Corp MIL:1BRKR
58 GF Score
Price €51.25
GF Value €52.04
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bruker Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bruker  (MIL:1BRKR) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bruker Cyclically Adjusted PS Ratio Related Terms


Bruker Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Bruker's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Cyclically Adjusted PS Ratio Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.54

Bruker Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.30 1.62 2.52 1.79 3.03

MIL:1BRKR vs PODD, BIO, GKOS: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Bruker's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bruker Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bruker's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bruker's Cyclically Adjusted PS Ratio falls into.


MIL:1BRKR
58GF Score
Bruker Corp MIL:1BRKR
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bruker Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bruker's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bruker's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.735/333.9520*333.9520
=4.735

Current CPI (Jun. 2026) = 333.9520.

Bruker Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 2.185 241.428 3.022
201612 2.714 241.432 3.754
201703 2.250 243.801 3.082
201706 2.351 244.955 3.205
201709 2.339 246.819 3.165
201712 2.894 246.524 3.920
201803 2.237 249.554 2.994
201806 2.372 251.989 3.144
201809 2.549 252.439 3.372
201812 3.082 251.233 4.097
201903 2.573 254.202 3.380
201906 2.768 256.143 3.609
201909 3.012 256.759 3.918
201912 3.487 256.974 4.532
202003 2.477 258.115 3.205
202006 2.492 257.797 3.228
202009 2.837 260.280 3.640
202012 3.422 260.474 4.387
202103 3.006 264.877 3.790
202106 3.099 271.696 3.809
202109 3.380 274.310 4.115
202112 3.921 278.802 4.697
202203 3.503 287.504 4.069
202206 3.686 296.311 4.154
202209 4.268 296.808 4.802
202212 4.699 296.797 5.287
202303 4.327 301.836 4.787
202306 4.242 305.109 4.643
202309 4.635 307.789 5.029
202312 5.444 306.746 5.927
202403 4.558 312.332 4.874
202406 5.025 314.175 5.341
202409 5.177 315.301 5.483
202412 6.042 315.605 6.393
202503 5.013 319.799 5.235
202506 4.638 322.561 4.802
202509 4.851 324.800 4.988
202512 5.505 324.054 5.673
202603 4.609 330.213 4.661
202606 4.735 333.952 4.735

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bruker (MIL:1BRKR) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €51.25 is trading 1.5% below its estimated GF Value™ of €52.04. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for MIL:1BRKR:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: €52.04 vs. price of €51.25 (1.5% below fair value)
  • GF Score™: 58/100 with 7 warning signs

No single metric tells the full story. See the MIL:1BRKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
58GF Score

Get the complete analysis for MIL:1BRKR

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.25
Price
€52.04
GF Value